PAPER Le R, Cruz L, Urbanc B, Knowles RB, Hsiao-Ashe K, Duff K, Irizarry MC, Stanley HE, Hyman BT

Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruption.

J Neuropathol Exp Neurol. 2001 Aug;60(8):753-8. PubMed.

PAPER Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA

Oxidative damage is the earliest event in Alzheimer disease.

J Neuropathol Exp Neurol. 2001 Aug;60(8):759-67. PubMed.

PAPER Mori T, Paris D, Town T, Rojiani AM, Sparks DL, Delledonne A, Crawford F, Abdullah LI, Humphrey JA, Dickson DW, Mullan MJ

Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APP(SW) mice.

J Neuropathol Exp Neurol. 2001 Aug;60(8):778-85. PubMed.

PAPER Law A, Gauthier S, Quirion R

Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta-amyloid toxicity.

Br J Pharmacol. 2001 Aug;133(7):1114-24. PubMed.

PAPER De Jonghe C, Esselens C, Kumar-Singh S, Craessaerts K, Serneels S, Checler F, Annaert W, Van Broeckhoven C, De Strooper B

Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability.

Hum Mol Genet. 2001 Aug 1;10(16):1665-71. PubMed.

PAPER Casadei VM, Ferri C, Calabrese E, Grimaldi LM, Franceschi M, Veglia F, Licastro F, Mariani C

Prion protein gene polymorphism and Alzheimer's disease: one modulatory trait of cognitive decline?

J Neurol Neurosurg Psychiatry. 2001 Aug;71(2):279-80. PubMed.

PAPER Winterle JS, Mill T, Harris T, Goldbeck RA

Absolute kinetic characterization of 17-beta-estradiol as a radical-scavenging, antioxidant synergist.

Arch Biochem Biophys. 2001 Aug 15;392(2):233-44. PubMed.

PAPER Manthey D, Heck S, Engert S, Behl C

Estrogen induces a rapid secretion of amyloid beta precursor protein via the mitogen-activated protein kinase pathway.

Eur J Biochem. 2001 Aug;268(15):4285-91. PubMed.

PAPER Trabace L, Cassano T, Cagiano R, Tattoli M, Pietra C, Steardo L, Kendrick KM, Cuomo V

Effects of ENA713 and CHF2819, two anti-Alzheimer's disease drugs, on rat amino acid levels.

Brain Res. 2001 Aug 10;910(1-2):182-6. PubMed.

PAPER Kanski J, Drake J, Aksenova M, Engman L, Butterfield DA

Antioxidant activity of the organotellurium compound 3-[4-(N,N-dimethylamino)benzenetellurenyl]propanesulfonic acid against oxidative stress in synaptosomal membrane systems and neuronal cultures.

Brain Res. 2001 Aug 17;911(1):12-21. PubMed.

PAPER Ruitenberg A, Kalmijn S, de Ridder MA, Redekop WK, van Harskamp F, Hofman A, Launer LJ, Breteler MM

Prognosis of Alzheimer's disease: the Rotterdam Study.

Neuroepidemiology. 2001 Aug;20(3):188-95. PubMed.

PAPER Poduslo JF, Curran GL, Wengenack TM, Malester B, Duff K

Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.

Neurobiol Dis. 2001 Aug;8(4):555-67. PubMed.

PAPER White F, Nicoll JA, Roses AD, Horsburgh K

Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion.

Neurobiol Dis. 2001 Aug;8(4):611-25. PubMed.

PAPER Steinhoff T, Moritz E, Wollmer MA, Mohajeri MH, Kins S, Nitsch RM

Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques.

Neurobiol Dis. 2001 Aug;8(4):647-54. PubMed.

PAPER Steiner H, Winkler E, Shearman MS, Prywes R, Haass C

Endoproteolysis of the ER stress transducer ATF6 in the presence of functionally inactive presenilins.

Neurobiol Dis. 2001 Aug;8(4):717-22. PubMed.